Merck & Company(CH:6MK)
CHF 96.580.00 (0.00%)
CH:6MK
Merck & Company earnings date
CHF 96.58
At close:0.00 (0.00%)
Merck & Company (6MK) Q2 2021 Earnings Report
0 Followers
CH:6MK Q2 2021 EPS Results
- Actual EPS
- CHF 1.09
- Consensus EPS
- CHF 1.09
- Beat/Miss
- Beat by +CHF 0.00
- One Year Ago EPS
- CHF 1.09
CH:6MK Q2 2021 Revenue Results
- Actual Revenue
- CHF 9.48B
- Expected Revenue
- CHF 9.38B
- Beat/Miss
- Beat by +CHF 98.00M
- YoY Revenue Growth
- +4.79%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/29/2021
- Time
- Before Open
- Conference Call
- Thursday, July 29, 2021
CH:6MK Upcoming Earnings
Merck & Company's next earnings date is estimated for February 2, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:6MK Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 02, 2027 | 2026 (Q4) | 1.47- | 1.7 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.742.08 | 2.16 | -3.49% (-0.08) | |
| Aug 04, 2026 | 2026 (Q2) | -0.23-0.11 | 1.78 | -106.10% (-1.89) | |
| Apr 30, 2026 | 2026 (Q1) | -1.23-1.07 | 1.85 | -157.66% (-2.92) | |
| Feb 03, 2026 | 2025 (Q4) | 1.681.70 | 1.44 | 18.60% (+0.27) | |
| Oct 30, 2025 | 2025 (Q3) | 1.972.16 | 1.31 | 64.33% (+0.84) | |
| Jul 30, 2025 | 2025 (Q2) | 1.701.78 | 1.9 | -6.58% (-0.13) | |
| Apr 24, 2025 | 2025 (Q1) | 1.781.85 | 1.73 | 7.25% (+0.13) | |
| Feb 04, 2025 | 2024 (Q4) | 1.341.44 | 0.03 | 5633.33% (+1.41) | |
| Oct 31, 2024 | 2024 (Q3) | 1.241.31 | 1.78 | -26.29% (-0.47) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
